BHV-7000 Open-Label Extension Bipolar Mania Study

Stopped early · Phase 2

Conditions studied: Bipolar Disorder

In brief

The purpose of this study is to evaluate the long-term safety and tolerability of BHV-7000 in subjects with bipolar I disorder.

Key facts

Study ID
NCT06423794
Run by
Biohaven Therapeutics Ltd.
People needed
94
Starts
2024-06-24
Expected to finish
2025-04-25
Last updated by the study team
2025-12-16

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.